A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder

Clinical trial NCT00621777 · COMPLETED

Trial details

NCT number: NCT00621777
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Bipolar Disorder Smoking

Start date: 2008-02-01
Primary completion: 2013-05-01
Enrollment: 247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.